Buyers eye Relypsa and its hyperkalemia drug

Eric Palmer Redwood City, CA-based Relypsa has hired an investment bank to check out M&A offers, Reuters reported. Relypsa isn't commenting but the news service says several ...

Virtual biotechs a hit with investors and, increasingly, buyers

Damian Garde Biotech venture capitalists have increasingly embraced the virtual model, seeding companies with promising assets, tiny staffs and a willingness to outsource. Now, as Reuters ...

Glaxo seeks buyers for older products worth up to $12.6B

Carly Helfand GlaxoSmithKline has already made some moves to sell off some of its older meds. But now, it's making more that could end up much, much bigger. FiercePharma News

Drug buyers sue Novo Nordisk over ‘wrongful’ delays to diabetes generic

Carly Helfand The Federal Trade Commission may now have the right to challenge pay-for-delay deals, but drugmakers can still stall the launches of competing generic products. And that's ...

New reports put India’s Torrent at forefront of buyers for Elder Pharmaceuticals

Eric Palmer The Economic Times now says Elder is deep into discussions with Indian drugmaker Torrent Pharma, which is talking about 1,700 crore ($ 291 million) for its peer. FiercePharma ...

Wanted: Buyers for Aptalis Pharma. Must be willing to pay $3B-plus

Carly Helfand Private equity firms have been among the busiest buyers and sellers in pharma in recent months. Now TPG is reportedly exploring a sale of specialty drugmaker Aptalis Pharma, ...

Deal buzz: Alkermes, Jazz Pharma could beckon buyers in Irish tax haven

Ryan McBride For some pharma dealmakers, corporate domiciles in Ireland have become hot commodities. The Irish tax code figured prominently in two recent biopharma buyout deals, and, ...

Analysis: A long lineup of potential buyers crowds Onyx picture

John Carroll Now that Onyx has put out the 'for sale' sign after confirming–and rejecting–Amgen's $ 10 billion-or-so offer for the company, the speculation ...

Private equity buyers eye offer for GlaxoSmithKline’s drinks brands

Tracy Staton Private equity firms Blackstone and Lion Capital are together eyeing an offer for GlaxoSmithKline's drinks brands Lucozade and Ribena. FiercePharma News

Russia’s Pharmstandard eyes buyers for $2.5B OTC drug business

Tracy Staton In the market for over-the-counter drugs in Russia? Pharmstandard may have a deal for you. The country's biggest drugmaker, Pharmstandard is said to be weighing a sale ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS